Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes
- 31 May 2007
- journal article
- research article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 45 (5) , 953-961
- https://doi.org/10.1016/j.jvs.2006.12.057
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Wound healing and functional outcomes after infrainguinal bypass with reversed saphenous vein for critical limb ischemiaJournal of Vascular Surgery, 2006
- Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemiaJournal of Vascular Surgery, 2006
- Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trialThe Lancet, 2005
- A new look at outcomes after infrainguinal bypass surgery: traditional reporting standards systematically underestimate the expenditure of effort required to attain limb salvageJournal of Vascular Surgery, 2004
- Increase in Peripheral Blood Flow by Intravenous Administration of Prostaglandin E1 in Patients with Peripheral Arterial Disease, Accompanied by Up-Regulation of Hepatocyte Growth FactorHypertension Research, 2004
- Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cellsBlood, 2003
- Clinical benefit of Prostaglandin E1-treatment of patients with ischemic heart disease: stimulation of therapeutic angiogenesis in vital and infarcted myocardiumBiomedicine & Pharmacotherapy, 2003
- Postoperative and amputation-free survival outcomes after femorodistal bypass grafting surgery: Findings from the Department of Veterans Affairs National Surgical Quality Improvement ProgramJournal of Vascular Surgery, 2001
- Vascular adhesion molecule-1 and markers of platelet function before and after a treatment with iloprost or a supervised physical exercise program in patients with peripheral arterial disease.Life Sciences, 2001
- Medical Treatment of Peripheral Arterial Disease and ClaudicationNew England Journal of Medicine, 2001